TPTX : Insider Transactions for Turning Point Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Turning Point Therapeutics, Inc. (TPTX)

$76.01 0.00 (0.00%) as of 4:30 Tue 8/16

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

48,170,000

Market Cap:

3.66(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$76.01 - $76.01

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 116

Guru Rank Value : 7.9

Guru Occurances : 1


6 Months 1 Year 2 Year


Company Profile

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	1,183
Total Sell Value	$0	$0	$0	$88,654
Total People Sold	0	0	0	1
Total Sell Transactions	0	0	0	1
End Date	2024-03-10	2023-12-08	2023-06-09	2022-06-09

Adjust Filter Settings

Records found: 142

Page 5 of 6

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Cui Jingrong Jean

Chief Scientific Officer

• • –

2020-01-27

4

AS

$56.82

$403,652

I/I

(7,000)

862,219

6%

Cui Jingrong Jean

Chief Scientific Officer

• • –

2020-01-15

4

AS

$53.03

$610,853

I/I

(11,500)

869,219

19%

Cui Jingrong Jean

Chief Scientific Officer

• • –

2020-01-14

4

AS

$52.44

$990,811

I/I

(18,500)

880,719

11%

Cui Jingrong Jean

Chief Scientific Officer

• • –

2020-01-13

4

AS

$52.49

$978,073

I/I

(18,500)

899,219

13%

Cui Jingrong Jean

Chief Scientific Officer

• • –

2020-01-10

4

AS

$54.00

$1,067,161

I/I

(18,500)

917,719

5%

Cui Jingrong Jean

Director

– • –

2019-12-30

4

OE

$5.12

$86,344

I/I

16,864

890,383

-

Cui Jingrong Jean

Director

– • –

2019-12-27

4

OE

$3.20

$179,456

I/I

38,080

873,519

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-20

4

AS

$62.64

$729,150

I/I

(11,500)

936,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-19

4

AS

$59.84

$1,130,257

I/I

(18,500)

947,719

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-18

4

AS

$57.76

$1,095,170

I/I

(18,500)

966,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-17

4

AS

$60.30

$1,134,374

I/I

(18,500)

984,719

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-16

4

AS

$55.45

$671,077

I/I

(11,500)

1,003,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-13

4

AS

$55.43

$641,169

I/I

(11,500)

1,014,719

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-12

4

AS

$53.18

$622,291

I/I

(11,500)

1,026,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-11

4

AS

$52.72

$608,787

I/I

(11,500)

1,037,719

-

Baker Brian Lee

VP of Finance and Admin.

• – –

2019-12-10

4

A

$31.13

$6,723

D/D

216

3,016

-

Countouriotis Athena

President & CEO

• • –

2019-12-10

4

A

$31.13

$21,976

D/D

706

22,706

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-10

4

AS

$53.79

$627,631

I/I

(11,500)

1,049,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-09

4

AS

$54.33

$636,229

I/I

(11,500)

1,060,719

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-06

4

AS

$50.67

$2,583,588

I/I

(50,890)

1,072,219

-

Cui Jingrong Jean

Chief Scientific Officer

• • –

2019-12-05

4

AS

$50.93

$2,914,936

I/I

(56,110)

1,123,109

-

Glaxosmithkline Plc

Director

– • –

2019-09-10

4

B

$45.00

$7,999,965

I/I

177,777

2,170,327

2.1

-

Countouriotis Athena

President & CEO

• • –

2019-09-10

4

B

$45.00

$450,000

D/D

10,000

22,000

2.81

-

EVP & Chief Financial Officer

• – –

2019-09-10

4

B

$45.00

$99,990

D/D

2,222

2,222

2.74

-

Director

– • –

2019-09-10

4

B

$45.00

$7,999,965

I/I

177,777

2,170,327

2.1

-

142 Records found	1 2 3 4 5 6	Page 5 of 6

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.